120 related articles for article (PubMed ID: 5686275)
1. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia.
Kessel D; Shurin SB
Biochim Biophys Acta; 1968 Sep; 163(2):179-87. PubMed ID: 5686275
[No Abstract] [Full Text] [Related]
2. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
Shrecker AW; Urshel MJ
Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
[No Abstract] [Full Text] [Related]
3. Occurrence of deaminated monophosphate nucleotide in extracellular sites after giving arabinofuranosylcytosine or deoxycytidine to mice.
Chou TC; Hutchison DJ; Schmid FA; Philips FS
Ann N Y Acad Sci; 1975 Aug; 255():287-91. PubMed ID: 1059362
[No Abstract] [Full Text] [Related]
4. The determination of the uptake of arabinosyl-6-mercaptopurine by L1210 cells.
Chao DL; Kimball AP
Biochim Biophys Acta; 1972 Jun; 266(3):721-5. PubMed ID: 5040251
[No Abstract] [Full Text] [Related]
5. Transport and phosphorylation as factors in the antitumor action of cytosine arabinoside.
Kessel D; Hall TC; Wodinsky I
Science; 1967 Jun; 156(3779):1240-1. PubMed ID: 6025544
[TBL] [Abstract][Full Text] [Related]
6. Differential cytotoxicity of cytosine arabinoside toward murine leukemia L1210 cells and murine bone marrow progenitor cells inhibited in nucleoside transport by cimicifugoside.
Hemmi H
Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):565-8. PubMed ID: 6791252
[TBL] [Abstract][Full Text] [Related]
7. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
Grindey GB; Saslaw LD; Waravdekar VS
Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
[No Abstract] [Full Text] [Related]
8. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
Bach MK
Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
[No Abstract] [Full Text] [Related]
9. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
Schrecker AW
Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
[No Abstract] [Full Text] [Related]
10. Cytosine arabinoside uptake by tumour cells in vitro.
Mulder JH; Harrap KR
Eur J Cancer (1965); 1975 May; 11(5):373-9. PubMed ID: 1171764
[No Abstract] [Full Text] [Related]
11. ACTIVITY OF SELECTED COMPOUNDS IN SUBLINE OF LEUKEMIA L1210 RESISTANT TO CYTOSINE ARABINOSIDE (NSC-63878).
WODINSKY I; KENSLER CJ
Cancer Chemother Rep; 1964 Dec; 43():1-3. PubMed ID: 14250647
[No Abstract] [Full Text] [Related]
12. Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.
Cory AH; Shibley IA; Chalovich JM; Cory JG
J Biol Chem; 1993 Jan; 268(1):405-9. PubMed ID: 8380161
[TBL] [Abstract][Full Text] [Related]
13. Studies on a new mechanism of resistance of L5178Y murine leukemia cells to cytosine arabinoside.
Momparler RL; Chu MY; Fischer GA
Biochim Biophys Acta; 1968 Jul; 161(2):481-93. PubMed ID: 4174433
[No Abstract] [Full Text] [Related]
14. Modulation of cytarabine uptake and toxicity by dipyridamole.
King ME; Naporn A; Young B; Howell SB
Cancer Treat Rep; 1984 Feb; 68(2):361-6. PubMed ID: 6697325
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells.
Belt JA
Mol Pharmacol; 1983 Nov; 24(3):479-84. PubMed ID: 6314117
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
Takenaka T; Kimura K
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
[No Abstract] [Full Text] [Related]
17. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
Durham JP; Ives DH
Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509
[No Abstract] [Full Text] [Related]
18. Computer simulation of leukemia therapy: combined pharmacokinetics, intracellular enzyme kinetics, and cell kinetics of the treatment of L1210 leukemia by cytosine arabinoside.
Lincoln T; Morrison P; Aroesty J; Carter G
Cancer Treat Rep; 1976 Dec; 60(12):1723-39. PubMed ID: 1026330
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of combination chemotherapy of cytosine arabinoside (ara-C) and uracil arabinoside (ara-U) or tetrahydrouridine (THU) against murine leukemia L1210/0 in tumor-bearing mice.
Avramis VI; Powell W
Cancer Invest; 1987; 5(4):293-9. PubMed ID: 3664332
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of 5-aza-2'-deoxycytidine phosphorylation in mouse spleen and L1210 leukemic cell extracts.
Veselý J; Cihák A
Neoplasma; 1980; 27(2):121-7. PubMed ID: 6156420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
